Kazakh National Agency receives some $0.5mln
Kazakh National Agency for Technical Development received
$498,865 from the sale of shares of Tetraphase Pharmaceuticals - a
portfolio company of venture Flagship ventures fund 2004.
The agency reported that the fund distributed $7.6 million received
from the deal among its investors.
This is the first distribution to investors since the fund
creation.
The current portfolio of the venture fund consists of seven
companies which are on sale now : BIND Biosciences., Inc., Concert
Pharmaceuticals, Inc., Quanterix Corporation, T2 Biosystems, Inc.,
Black Duck, Inc., LS9, Inc. (Newco LS9, Inc), Mascoma
Corporation.
Kazakh National Agency for Technical Development decided to finance
the Fund. Flagship ventures fund 2004 in 2005. The fund invests in
such areas as biotechnology, nanotechnology, medicine and
information technology.
Here we are to serve you with news right now. It does not cost much, but worth your attention.
Choose to support open, independent, quality journalism and subscribe on a monthly basis.
By subscribing to our online newspaper, you can have full digital access to all news, analysis, and much more.
You can also follow AzerNEWS on Twitter @AzerNewsAz or Facebook @AzerNewsNewspaper
Thank you!